RT Journal Article
SR Electronic
T1 Endpoints in asthma drug trials - what do they mean?
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 21
OP 24
DO 10.1136/dtb.2006.44321
VO 44
IS 3
YR 2006
UL http://dtb.bmj.com/content/44/3/21.abstract
AB There are many potential outcomes or endpoints to choose from to assess the effects of asthma treatments, and a wide range of such measures are used in different trials. This can make it difficult to compare treatment outcomes from different trials and to understand whether new treatments offer a genuine clinical benefit for patients. Here we review the common endpoints used in trials to assess the efficacy of asthma treatments.